Infectious Diseases

2022 Activity indicators

  • 3 H2020 projects: IMI-COMBACTE-NET and Eranet TRASNCAN (SCRATCH), EDCTP
  • 12 national competitive public projects - ISCIII.
  • 12 private led projects.
  • 91 clinical led studies.
  • 11 competitive HR contracts.
  • 87 publications.
  • IF: 800.64
  • Publications in D1: 19 (22 %).
  • Publications in  Q1: 46 (53 %).
  • 2 supervised read thesis.
  • 5 consensus documents.
  • 1 technical document: GESIDA/SEMFYC
  • Project evaluators for national institutions: 10 PIs
  • Project evaluators for international institutions: 5 PIs
  • Members of editorial committees: 7 PIs
  • 1 European patent application (21382486.5.) "Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2".

Milestones

  1. Success in the AES 2022 and MICINN call for proposals with two health research projects (PI22/01370; PI22/01878); 2 competitive research contracts; 1 Rio Hortega (CM22/00069), 1 PFIS predoctoral contract (FI22/00111) & 1 postdoctoral contract (JR22/00008).

  2. Award of a MARIE SKŁODOWSKA-CURIE contract of excellence (MSCA-IF- 101064842) of the Horizon Europe program to the postdoctoral researcher Elena Moreno del Olmo and mentored by Dr. Sergio Serrano for the development of the project "MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental charac-terization and clinical exploitation".

  3. Participation in several consensus documents, care protocols, technical documents of which we highlight: 1) Consensus document of GeSIDA/National Plan on AIDS regarding antiretroviral treatment in adults infected by the human immunodeficiency virus (MICINN & GESIDA); 2) Shared management of patients with HIV infection between primary care and hospital (GESIDA & semFYC).

  4. Martínez-Sanz J, Serrano-Villar S, Muriel A, García Fraile LJ, Orviz E, Mena de Cea Á, Campins AA, Moreno S. Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study. Clin Infect Dis. 2023; 76(3):e652-e660. doi: 10.1093/cid/ciac621. PMID: 35903910.

  5. Crespillo-Andújar C, Comeche B, Hamer DH, Arevalo-Rodriguez I, Alvarez-Díaz N, Zamora J, Pérez-Molina JA. Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis. PLoS Negl Trop Dis. 2022; 16(5):e0010386. doi: 10.1371/journal.pntd.0010386. PMID: 35576215.

Bibliometrics

  Article Accum. FI Mean FI  Articles Q1 or Q2 % in Q1 or Q2 Articles D1 % on D1
2018 99 441,46 4,65 74 75 27 27
2019 105 371,58 3,91 67 64 21 20
2020 112 638,63 5,70 82 73 36 32
2021 100 673,17 6,73 76 76 26 26
2022 87 800,64 9,20 64 74 19 22
  503 2925,5 6,04 363 72 129 26

* Only original articles, editorials, guidelines & reviews